STOCKHOLDERS' EQUITY

12 Months Ended

Feb. 02, 2025

Equity [Abstract]

STOCKHOLDER'S EQUITY

STOCKHOLDERS’ EQUITY

Stock Rollforward

The following table presents a reconciliation of the number of shares of our common stock outstanding and cash dividends per share:

shares in millions	Fiscal		Fiscal		Fiscal
	2024		2023		2022
Common stock:
Shares at beginning of year	1,796		1,794		1,792
Shares issued under employee stock plans, net	4		2		2
Shares at end of year	1,800		1,796		1,794
Treasury stock:
Shares at beginning of year	(804)		(778)		(757)
Repurchases of common stock	(2)		(26)		(21)
Shares at end of year	(806)		(804)		(778)
Shares outstanding at end of year	994		992		1,016
Cash dividends per share	$	9.00	$	8.36	$	7.60

Share Repurchases

In August 2023, our Board approved a $15.0 billion share repurchase authorization that replaced the previous authorization of $15.0 billion, which was approved in August 2022. The August 2023 authorization does not have a prescribed expiration date. As of February 2, 2025, approximately $11.7 billion of the $15.0 billion share repurchase authorization remained available. In March 2024, we paused share repurchases in anticipation of the SRS acquisition (see Note 13 for details regarding the SRS acquisition).

The following table presents information about our repurchases of common stock, all of which were completed through open market purchases:

	Fiscal		Fiscal		Fiscal
in millions	2024		2023		2022
Total number of shares repurchased	2		26		21
Total cost of shares repurchased	$	599	$	8,074	$	6,504

The cost of shares repurchased may differ from the repurchases of common stock amounts in the consolidated statements of cash flows due to unsettled share repurchases at the end of a period and net excise taxes incurred on share repurchases.